From Nasdaq: 2025-05-13 00:46:00

Chemours (NYSE:CC) stock is deemed unattractive at its current price of around $11 due to major concerns with its operating performance and financial condition. Comparing CC’s valuation to the S&P 500, it appears cheap with a price-to-sales ratio of 0.3 and a price-to-earnings ratio of 21.8. However, CC’s revenues have been declining, and its profit margins are significantly lower than the S&P 500. The company’s balance sheet looks weak, with a high debt-to-equity ratio. While CC stock has shown some resilience during downturns, its overall performance is rated as very weak. Despite its low valuation, CC stock is considered unattractive, making it a bad buy. Consider exploring alternative investment options like the Trefis High Quality portfolio for better returns.



Read more at Nasdaq: Now Is Not The Time To Buy Chemours Stock